Medigen Vaccine Biologics (6547) — Financial Flexibility Index
Medigen Vaccine Biologics (6547) has a Financial Flexibility Index of -0.05x as of June 2026. Free cash flow of NT$-58.48 Million (operating CF NT$-91.20 Million minus capex NT$32.72 Million) represents 0% of total liabilities (NT$1.21 Billion). Check total reinvestment intensity of Medigen Vaccine Biologics to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Medigen Vaccine Biologics Financial Flexibility Index (2012–2025)
Historical Financial Flexibility Index trend for Medigen Vaccine Biologics across 14 annual periods. For the full cash flow conversion analysis, see Medigen Vaccine Biologics cash flow conversion.
Annual Financial Flexibility Index for Medigen Vaccine Biologics (2012–2025)
Year-by-year free cash flow to debt coverage for Medigen Vaccine Biologics. Explore Medigen Vaccine Biologics (6547) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.01x | NT$2.69 Million | NT$-49.09 Million | NT$454.64 Million | ▼ -96.0% |
| 2024 | 0.15x | NT$75.73 Million | NT$40.75 Million | NT$513.92 Million | ▲ +175.8% |
| 2023 | -0.19x | NT$-436.80 Million | NT$-477.75 Million | NT$2.25 Billion | ▲ +53.1% |
| 2022 | -0.41x | NT$-960.62 Million | NT$-1.10 Billion | NT$2.32 Billion | ▼ -136.1% |
| 2021 | 1.15x | NT$714.85 Million | NT$579.89 Million | NT$622.95 Million | ▲ +182.7% |
| 2020 | -1.39x | NT$-484.67 Million | NT$-589.97 Million | NT$349.40 Million | ▼ -265.7% |
| 2019 | -0.38x | NT$-345.27 Million | NT$-462.65 Million | NT$910.28 Million | ▲ +32.4% |
| 2018 | -0.56x | NT$-320.44 Million | NT$-356.33 Million | NT$571.10 Million | ▼ -169.6% |
| 2017 | -0.21x | NT$-128.06 Million | NT$-217.03 Million | NT$615.41 Million | ▼ -124.0% |
| 2016 | 0.87x | NT$301.05 Million | NT$-163.37 Million | NT$347.90 Million | ▼ -60.3% |
| 2015 | 2.18x | NT$673.41 Million | NT$216.26 Million | NT$309.19 Million | ▲ +473.1% |
| 2014 | -0.58x | NT$-79.37 Million | NT$-513.98 Million | NT$135.95 Million | ▲ +69.3% |
| 2013 | -1.90x | NT$-37.01 Million | NT$-72.36 Million | NT$19.46 Million | ▼ -142.4% |
| 2012 | 4.48x | NT$99.29 Million | NT$-5.47 Million | NT$22.15 Million | — |